Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NAD Research, Inc. is a Louisiana-based 501(c)(3) nonprofit scientific research organization established in 2017. The organization is dedicated exclusively to advancing the scientific and clinical understanding of nicotinamide adenine dinucleotide (NAD+), a foundational coenzyme essential for cellular energy, DNA repair, and sirtuin activation. In collaboration with clinics like the Springfield Wellness Center, NAD Research investigates the therapeutic applications of intravenous and intranasal NAD+ (specifically the proprietary BR+NAD® protocol). Its research focuses on treating chemical dependency, neurodegenerative diseases such as Alzheimer's and Parkinson's, and mental health conditions including depression, anxiety, and post-traumatic stress disorder.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NAD Research.